SlideShare a Scribd company logo
Prepared by: PARTH
Guided by: Dr. Ashok Mahajan

APMC College of Pharmaceutical
education and research,
Himmatnagar
INDEX
I.   Introduction
II. Need for a Preformulation study
III. Stages of Preformulation studies
IV. Analytical techniques and instruments for
     Preformulation studies
V. Regulatory requirements for Preformulation
VI. Appendix: Physicochemical properties and
     analytical testing for drug
VII. References
I .Introduction
 Definition: “Preformulation study is define as the process of
  optimizing the delivery of drug through determinations of
  physicochemical properties of the new compound that could affect
  drug performance and development of an efficacious, stable and
  safe dosage form.”

 Preformulation is the study of the chemical and physical properties
  of the drug components prior to the compounding process of the
  formulation.

 The purpose of the study is to understand the nature and
  characteristics of each component and to optimize conditions of the
  dosage form manufacture.
Essential information helpful in designing Preformulation evaluation of
  new drug:
1. Compound identity                       % volatiles
2. Structure                               Observations
3. Formula and molecular weight        7. Analytical methods
4.Therapeutic indication                   HPLC Assay
       Probable human dose                 TLC Assay
       Desired dosage form(s)              UV/VIS Spectroscopy
       Bioavailability model(s)            Synthetic route
       Competitive products                Probable decay products
5. Potential hazards                   8. Key dates
6. Initial bulk lots:                      Bulk scale up
       Lot number                          Toxicology start date
       Crystallization solvent(s)          Clinical supplies preparation
                                           IND filing
       Particle size range
                                           Phase I testing
       Melting point
II.Need for a Preformulation Study
 Scientific and regulatory justifications for acquiring preformulation
  data include the following.
   1.   Establishment of drug specifications intended for toxicologic
       evaluation and clinical supply preparations
   2. Formulation of clinical supplies and establishment of their
       preliminary Specifications
   3. Providing scientific data to support dosage form development
       and evaluation of product efficacy, quality, stability, and
       bioavailability
   4. Evaluation of the stability of early developed dosage forms
   5. Fulfillment of the requirement of the CMC section of the IND
       and subsequent NDA or ANDA
III. Stages of Preformulation Studies
 The preformulation is performed in several stages with different
  development cycles, which are discussed in the following.

 Preformulation Report, Part 1: Physicochemical Properties and
  Analytical Testing for Drugs

 Preformulation Report, Part 2: Data Supporting the
  Development of Dosage Forms

 Preformulation Report, Part 3: Support for Quality Control and
  Finished Product Manufacturing
IV.Analytical techniques and instruments for
preformulation studies:
 A preformulation study is performed to gain insight from
  physicochemical and biological data into the design and
  development of dosage forms.

 Samples are taken in each study and analyzed qualitatively and/or
  quantitatively, according to the need.

 Analytical techniques are generally divided into two prevalent
  areas in the specific detection and separation sciences.
Analytical Preformulation

           Attribute                               Test
Identity                  Nuclear magnetic resonance (NMR)
                          Infra red spectroscopy (IR)
                          Ultraviolet spectroscopy (UV)
                          Thin-layer chromatography (TLC)
                          Differential scanning calorimetry (DSC)
                          Optical rotation, where applicable

Purity                    Moisture (water and solvents)
                          Inorganic elements
                          Heavy metals
                          Organic impurities
                          Differential scanning calorimetry (DSC)
                          Melting point

Assay and Separation      Titration
                          Ultraviolet spectroscopy (UV)
                          High-performance liquid chromatography (HPLC)
                          Thin-layer chromatography (TLC)
A. Specific Detection
 Specific detection is based on specific responses related to the
  chemical characteristics of a molecule excited by a certain type of
  irradiation.
 In this detection method, measurement of the molecule of interest
  may usually be performed without separation from matrix
  materials or from other ingredients if appropriate instrumental
  adjustments are made.
 Techniques such as Fourier transform IR (FTIR), attenuated total
  reflectance (ATR), NIR, Raman spectroscopy are used with
  increased regularity.
 The detection of foreign metal contaminants is essential with
  inductively coupled plasma spectroscopy (ICP), atomic absorption
  (AA), and X-ray fluorescence.
1.UV spectroscopy
 UV absorptions are mainly electronic in nature and are associated with
  resonating structures in the molecule.
 The UV quantitative determination, generally performed in solution, is based
  on the Beer–Lambert law.
 In a Preformulation study, Certain UV techniques are worthy of discussion:
    Solubility,
    Dissolution rate,
    Molecular weight
    pKa
    Assay (potency)
    Mixtures:
    - resolving compound products
 Stability studies : hydrolysis, oxidation ,when degradation products
  have a different absorption maximum from the parent compound
 ionization of benzoic acid affect its aqueous solubility, is also manifested in the
  ultraviolet absorption spectrum.
 Figure shows the UV spectra obtained for a 5 mg/mL solution of benzoic acid in
  methanol (i.e., the protonated form) and for the same concentration of substance
  dissolved in 0.1N sodium hydroxide solution (i.e., the ionized form).
 The spectrum of the protonated form is dominated by the peak at 228nm (molar
  absorptivity =11,900 L/mole), while the analogous peak of the ionized form is
  slightly blue-shifted to 225nm and is significantly less intense (molar absorptivity
  ¼8640 L/mole)
2.IR Spectroscopy
 Used for fingerprint identification of a drug molecule and the proof
  of its structure.
 IR absorption bands are characteristic of the functional group of a
  molecule as well as the structure configuration.
 The wavelength of the IR spectrum is 750–2500 μm.
 The sampling preparation techniques for IR determination are
  solution, drug dispersion in a KBr pellet, Nujol mulls, and
  direct determination by microscopic ATR preparation.
 An example of modern IR equipment is FTIR, which gives
  better quality determination.
Analytical tech in pre formulation 112070804009
3.Raman Spectroscopy
 When a particle is irradiated at a certain frequency, radiation
  scattered by the molecule contains photons of the same frequency
  as the incident radiation and may contain photons (weak signal)
  with a changed or shifted frequency.
 A nondestructive tool and requires little or no sample preparation.
 A sample may be analyzed in solid or powder form or in an
  aqueous solution and placed in glass containers such as an NMR
  tube, GC vial, test tube, light-path cell, or glass bottle.
 Aside from structure elucidation and functional group analysis,
  FT-Raman may be used for quantitative determination of
  polymorphs in a Preformulation study.
4.NIR Spectroscopy
 NIR is making significant progress through recent advances in
    pharmaceutical analysis.
   The advantage of this technique is the rapidity of analytical
    determinations without sample preparation and the use of
    solvent.
   The NIR spectrum is primarily related to the overtone
    variation. Hence, the absorption bands are generally weaker
    than those in the IR.
   The wavelength of the NIR spectrum is defined as 2500–3000
    μm.
   The detection method is nondestructive.
   Therefore, it is suitable for use in on-line monitoring and meets
    100% inspection requirements in quality control practice.
5.X-Ray Diffraction
 obtains information on substance structure at the atomic
    level.
   This technique allows measurement of both crystalline and
    noncrystalline materials.
   The analysis is nondestructive in nature and handles
    samples in the form of powders, solids, and liquids.
   The X-ray diffraction of a single crystal is employed for the
    determination of the absolute chemical structure.
   Quantitative ratios of two polymorphs and their
    percentage of crystallinity may also be determined.
 the XRPD pattern of benzoic acid is shown in Figure
 One may define this particular crystal form by the angles of the five
  most intense scattering peaks, namely 8.15, 10.21, 16.24, 17.20, and
  21.67 degrees 2q. Through use of the Bragg equation ,nzλ= 2d sin θ,
  calculated d-spacings for the five most intense scattering peaks,
  namely 10.840, 8.657, 5.453, 5.151, and 4.098 A ° , actually constitute a
  better definitionof this particular crystal form.
6. NMR Spectroscopy
 NMR involves the absorption of electromagnetic radiation in the
    radiofrequency of a longer wavelength spectrum.
   When a sample is placed with atomic nuclei of hydrogen (1H,
    protons), fluorine (15F), or phosphorous (31P) in a magnetic field,
    absorption of energy will occur.
   The nuclei shift from the preferred orientation with lowest energy
    to a less preferred, high-energy orientation at a particular
    frequency.
   Thus a plot of frequency versus intensity of radiation results in the
    NMR spectrum of a material.
   Spectra of NMR can be obtained in liquids or in solids.
   NM R spectra gives information about structure and atomic
    environment of molecule,
 It consist of resonance bands associated with the carbon
 atoms in the aromatic nucleus and the carbon atom of the
 carboxylic acid group.
7. Mass Spectroscopy
 Mass spectra is the result of detection of charged particles or
  ions separated according to their mass to charge (m/e) ratio
  after ionization and acceleration through magnetic field.

 Mass spectra gives information about molecular weight of
  substance and what its degraded or metabolic products will be.

 MALDI like techniques are employed for high molecular
  weight substances like certain proteins.
8. Metal analysis
a) Atomic absorption spectroscopy
b) ICP Spectroscopy
c) X-Ray fluorescence
 Pharmaceutical compounds such as ferrous sulfate, ferrous
   gluconate, zinc undecylenate, and magnesium stearate (a
   commonly used excipient)
 Sodium, potassium, zinc detection for certain preparations like
   protamine zinc insulin etc.
 presence of metal in pharmaceuticals, even in trace amounts, is a
   form of contaminant. For example, metallic ions may act as a
   catalyst in oxidation that may be detected in drug products.
B. Separation Sciences
1.    Thin-Layer Chromatography
      impurity profiling in drug development
      Involves most convenient, least inexpensive and portable
       equipment
      microscopic technique (it uses a very small sample) is
       simple and has a short development time
      general detection technique is to spray a sample with a
       detecting agent, which reacts chemically with the
       ingredient to be detected or visual observation under
       short- or long-wave UV light is also employed.
      The disadvantages of TLC include reproducibility,
       detection inconsistency, person-to-person variations,
       documentation, and electronic data reduction.
 HPTLC:
 to overcome some drawbacks of TLC, especially in
  quantitative determination, A high-performance instrument
  has been developed with
    a fully automated sample applicator,
    a solvent-developing and -evaporating chamber,
    a precision-made dryer,
    a color developing agent
    sprayer,
    a light control chamber for visual or photographic
     observation, and a reflective spectrophometric detector
 Ingenious methods of quantitative determination are available
  that use a flame ionization detector (FID)
2. High-Pressure Liquid Chromatography
 HPLC is used extensively in the laboratory for quantization of
   drugs and related components. Identification of a drug
   component can simultaneously be determined by retention
   times in the chromatogram.
 reliable analytical tool for Preformulation study because of
   the high-resolution capacity, accuracy, and reproducibility of
   the equipment
 Its primary function includes
     search for and detection of impurities in drug substances,
     stability evaluation of dosage forms in terms of detection
      and quantization of degradation products.
 UV detector coupling with Micro-bore HPLC equipment is the
   most important analytical instrument for Preformulation
3. Capillary Electrophoresis:
 A separate technique employing narrow-bore tubes (10–200
   μm i.d.) for high-efficiency resolution of both large and small
   molecules
 In free solution capillary electrophoresis (CE), the separation
   and migration of the molecules through the capillary are
   based on electrophoretic migration (based on net charge)
   and electrosomotic flow (the bulk flow of electrolyte buffer)
 Other mechanisms for separation depend on molecular size,
   isoelectric focusing, and hydrophobicity
 Modification of CE is micellar electrokinetic
   chromatography (MEKC), widely used for the separation of
   nonpolar compounds
4. Gas Chromatography:
 GC is used for speedy separation or for high-resolution
   separation of volatile or thermal labile substances. GC has
   good sensitivity, with detection limits of 1 ppb to 100 ppm.
 With the advances in HPLC, GC is utilized less often. It is still
   used for the analysis of retained solvents, such as the USP test
   for volatile organic solvents.
5. Ion Chromatography:
 Ion chromatography is a modified version of HPLC with a
   capacity for precise and highly sensitive detection of inorganic
   ions in a complex matrix.
 IC has instrumental configurations similar to those of HPLC,
   but the stationary phase is an ion-exchange column, and the
   detector can be either an electrochemical detector or a
   colorimeter with a mixer to carry out color formation by
   chemical reaction with the detected ion
6. Supercritical Fluid Chromatography:

 SFC uses highly compressed gas above its critical
  temperature and pressure instead of an organic solvent
  as the solvent phase
 Gases such as carbon dioxide, nitrous oxide, and
  ammonia are commonly used
 The SFC detecting systems are those commonly used in
  GC, that is, FID.
 Major advantage is allowance in the analysis for thermal
  unstable compounds
C .Thermal Analytical methods
1) Differential Scanning Calorimetry
2) Hot Stage Microscopy
3) Thermal Gravimetric Analysis
4) Solution Calorimetry
 DSC is a precise method of measuring the endothermic and
  exothermic behaviors of sample materials.
 TGA measures the weight change (gains and losses) as a
  function of temperature or time is recorded which provides
  information about the material’s thermal stability and
  compositional analysis (e.g., moisture content of the
  materials).
 The gas evolved during the heating process may be
  detected with FTIR or MS to provide additional
  information.
 TGA may be used to determine moisture content related to
  weight loss in isothermal or nonisothermal stability
  studies.
 Preformulation study, differentiation of polymorph from
  hydrate or identification of monohydrate from among
  other hydrates by DSC alone may not be possible.
 The DSC thermogram of benzoic acid is shown and is seen to consist
    entirely of an endothermic transition associated with the melting
     phase transition of the compound.
    No thermal events were observed at the lower temperatures
     indicative of the existence of a solvatomorphic crystal form.
    Under the conditions of measurement, the melting endothermic
     transition is characterized by an onset temperature of 121.9C, a peak
     maximum of 123.7C, and an enthalpy of fusion equal to 138.9 J/g
V. Regulatory requirements for Preformulation
A. Regulatory Compliance:
 FDA initiatives and other government regulations influence
  pharmaceutical manufacturing operations, including
  Preformulation studies and quality control systems.
1) Current Good Manufacturing Practices:
    The cGMP is an FDA mandatory quality program designed to
       ensure that pharmaceutical products are consistently produced
       and controlled according to the quality standards appropriate
       to their intended use.
2) Good Laboratory Practice:
    GLP covers research activities like raw data,
       documentation, standard operating procedures (SOP),
       protocols, final reports, and specimens (with some
       exceptions) must be retained.
3) International Conference on Harmonization:
 The ICH is intended to avoid duplication efforts for product
  registration and manufacturing in world trade from the United
  States, the European Union, and Japan to harmonize regulatory
  criteria and procedures.
 Ultimately, there will be one set of global requirements. Area of
  interest are
     Stability testing
     Quality specification (including impurities)
     Validation of manufacturing procedures and analytical
      methods
     CMC sections for product registration
     Toxicity testing
     Clinical testing of biotechnology-derived products
B. Quality Control for a Preformulation Study
 Personnel Qualification and Training
 Analytical Method Validation
    Written analytical procedure
    Instrument calibration
    Validation parameters: accuracy, precision, linearity,
     sensitivity
    System suitability criteria: the minimum acceptable
     performance criteria before each analysis
 Documentation and Standard Operating Procedures
APPENDIX 1: PHYSICOCHEMICAL PROPERTIES AND
ANALYTICAL TESTING FOR DRUG SUBSTANCE
                            Chemical Structure
Empirical Formula                                       Molecular Weight
 Lot # of Drug Used:                                    Reported By:
 Assay:                                                 Position:
 Reference: Notebook #                                  Date of Report Issued:
1. Chemical Properties                       2. Identification of Drug Substance
Chemical structure                          UV
Molecular weight                            IR
Empirical formula                           NMR
Elemental analysis (C, H, N, O, Cl, etc.)   Mass spectroscopy
                                             TLC Rf and HPLC retention time
                                             Melting point
3. Titration Methods               6. Synthetic Impurities
Nonaqueous titration with curve    Starting materials a: name and
Other titration methods               structure
4. Chromatographic Techniques       Pivotal impurities b: name and
and Method Description                 structure
     TLC                           Degradant from synthesis c: name and
     HPLC                             structure
     GPC                           Other minor impurities d: name and
     Others                           structure
5. Proposed Assay Methods for       Description of Method of Detection
Drug Substance                     7. HPLC Data
     Titration                    Impurities Retention Time
      UV                          1.
      HPLC                        2.
      GC                          3.
      Others                      Typical chromatogram attached
     Description                  8. Optical Rotation
                                   Typical spectrograph attached (Figure )
                                   Comments
9. Solubility                                  11. Partition Coefficient
 Solubility in water and organic solvents:    Value:
mg/ml                                          System:
 Aqueous Solubility as a Function of          12. Loss on Drying
Temperature                                    Drying temperature:
Temperature ( C) Solubility :mg/ml             Time period:
Aqueous Solubility at Various Buffered pH     Condition: _ in oven, _ in vacuo
Values                                         LOD in percent:
pH Solubility (mg/ml)
Buffer system
Solubility with Surfactants
Surfactant/Concentration Solubility (mg/ml)
10. Dissociation Constant, pKa
pKa value:
Method of determination:
VII . References
1. Satinder Ahuja, Stephen Scypinski, Handbook of Modern
     Pharmaceutical Analysis, pp173-233.
2.   Leon Lachman, Herbet A.Lieberman, A theory and practice of
     Industrial Pharmacy, special Indian edition -2009,pp 171-196
3.   M.E.Aulton, Pharmaceutics The science of Dosage Form
     Design, Second edition, pp113-138
4.   Gilbert S. Banker, Christopher T. Rhodes, Modern
     Pharmaceutics, Fourth edition, Marcel dekker,Inc.
5.   Moji Christianah Adeyeye , Harry G. Brittain,
     Preformulation in solid dosage form development, Informa
     healhcare Inc.-2008,pp1-15,115-145.
Analytical tech in pre formulation 112070804009

More Related Content

PPTX
Parameters in Preformulation Studies
PPT
Rate-Controlled Drug Delivery System
PPTX
Theories of dispersion
PPTX
Misbranded and spurious cosmetics
PPTX
Granulation ppt.
PPTX
factors affecting dissolution rate a full view.
PPTX
Dissolution methods
PPTX
Drug excipient interaction different method
Parameters in Preformulation Studies
Rate-Controlled Drug Delivery System
Theories of dispersion
Misbranded and spurious cosmetics
Granulation ppt.
factors affecting dissolution rate a full view.
Dissolution methods
Drug excipient interaction different method

What's hot (20)

PPT
Mucoadhesive drug delivery system
PPT
Microencapsulation (2)
PPTX
Friability testing
PPTX
Preformulation concept
PPTX
Compaction profiles
PPTX
Physics of tablet compression (compression & compaction)
PPTX
Mechanism of dds1
PPT
PILOT PLANT DESIGN FOR TABLETS
PPTX
Preformulation studies
PDF
Phase solubility analysis and pH solubility profile
PPTX
salt selection in pharmaceutical product development
PPTX
Dissolution and drug release testing
PPTX
Study of consolidation parameters
PPTX
Drug excipient interaction: different method
PDF
PERSONALIZED MEDICINE,CUSTOMIZED DRUG DELIVERY SYSTEM ,3D PRINTING ,TELEPHARM...
PPTX
Polymers of Controlled Drug Delivery System
PPTX
Compendial methods of dissolution
PPTX
Large & Small Volume Parenteral
PPT
Nasal & Pulmonary Drug Delivery System
PDF
NIOSOME, ITS PREPARATION AND EVALUATION
Mucoadhesive drug delivery system
Microencapsulation (2)
Friability testing
Preformulation concept
Compaction profiles
Physics of tablet compression (compression & compaction)
Mechanism of dds1
PILOT PLANT DESIGN FOR TABLETS
Preformulation studies
Phase solubility analysis and pH solubility profile
salt selection in pharmaceutical product development
Dissolution and drug release testing
Study of consolidation parameters
Drug excipient interaction: different method
PERSONALIZED MEDICINE,CUSTOMIZED DRUG DELIVERY SYSTEM ,3D PRINTING ,TELEPHARM...
Polymers of Controlled Drug Delivery System
Compendial methods of dissolution
Large & Small Volume Parenteral
Nasal & Pulmonary Drug Delivery System
NIOSOME, ITS PREPARATION AND EVALUATION
Ad

Similar to Analytical tech in pre formulation 112070804009 (20)

PPTX
PREFORMULATION.pptx
PPTX
Preformulation studies
PPT
Preformulation testing of solid dosage forms
PPT
Pharmaceutical preformulation's
PPTX
Umesh bhandari
PPT
Pre formulation
PPTX
Preformulation.pptx
PPTX
preformulation
PPT
Preformulation studies for bulk characterization
PPTX
Preformulation and product development
PPTX
Preformulation Power Point Presentation
PPTX
preformulation study ralated to pharmaceuticals
PPTX
B.Pharm - IP-I Unit I - Preformulation.pptxB
PPTX
Preformulation
PDF
Industrial Pharmacy Notes for M.Pharmacy
PPT
Preformulation -1.- Industrial Pharmacyppt
PPTX
Preformulation.
PPTX
Preformulation Studies of Herbal Cosmetics
PPTX
Pre-Formulation
PREFORMULATION.pptx
Preformulation studies
Preformulation testing of solid dosage forms
Pharmaceutical preformulation's
Umesh bhandari
Pre formulation
Preformulation.pptx
preformulation
Preformulation studies for bulk characterization
Preformulation and product development
Preformulation Power Point Presentation
preformulation study ralated to pharmaceuticals
B.Pharm - IP-I Unit I - Preformulation.pptxB
Preformulation
Industrial Pharmacy Notes for M.Pharmacy
Preformulation -1.- Industrial Pharmacyppt
Preformulation.
Preformulation Studies of Herbal Cosmetics
Pre-Formulation
Ad

More from Patel Parth (20)

PPT
Automated analysis by yatin sankharva copy
PPT
Automated analysis 112070804013
PPT
Anda registration in us eu
PPTX
Anda ppt
PPTX
Analysis of solid oral
PPTX
Analysis of solid oral dosage forms 112070804010
PPTX
Analysis of parenteral dosage forms bjl final seminar
PPTX
Analysis of data (pratik)
PPTX
Analysis of cosmetics 112070804018
PPT
Agencies dhwani
PPTX
A seminar on applications of various analytical technique
PPT
23117 copy of oral solid dosage forms
PPTX
4016 solid state analysis
PPT
4003 regulatory aspect_of_bulk,pharmaceutical,biotech
PPTX
A.a sequence analysis 112070804002
PPTX
Chi square test
PPTX
Sterility testing 112070804014
PPT
Ria 112070804007
PPTX
Qc lab 112070804001
PPT
Pyrogen testing 112070804005
Automated analysis by yatin sankharva copy
Automated analysis 112070804013
Anda registration in us eu
Anda ppt
Analysis of solid oral
Analysis of solid oral dosage forms 112070804010
Analysis of parenteral dosage forms bjl final seminar
Analysis of data (pratik)
Analysis of cosmetics 112070804018
Agencies dhwani
A seminar on applications of various analytical technique
23117 copy of oral solid dosage forms
4016 solid state analysis
4003 regulatory aspect_of_bulk,pharmaceutical,biotech
A.a sequence analysis 112070804002
Chi square test
Sterility testing 112070804014
Ria 112070804007
Qc lab 112070804001
Pyrogen testing 112070804005

Analytical tech in pre formulation 112070804009

  • 1. Prepared by: PARTH Guided by: Dr. Ashok Mahajan APMC College of Pharmaceutical education and research, Himmatnagar
  • 2. INDEX I. Introduction II. Need for a Preformulation study III. Stages of Preformulation studies IV. Analytical techniques and instruments for Preformulation studies V. Regulatory requirements for Preformulation VI. Appendix: Physicochemical properties and analytical testing for drug VII. References
  • 3. I .Introduction  Definition: “Preformulation study is define as the process of optimizing the delivery of drug through determinations of physicochemical properties of the new compound that could affect drug performance and development of an efficacious, stable and safe dosage form.”  Preformulation is the study of the chemical and physical properties of the drug components prior to the compounding process of the formulation.  The purpose of the study is to understand the nature and characteristics of each component and to optimize conditions of the dosage form manufacture.
  • 4. Essential information helpful in designing Preformulation evaluation of new drug: 1. Compound identity % volatiles 2. Structure Observations 3. Formula and molecular weight 7. Analytical methods 4.Therapeutic indication HPLC Assay Probable human dose TLC Assay Desired dosage form(s) UV/VIS Spectroscopy Bioavailability model(s) Synthetic route Competitive products Probable decay products 5. Potential hazards 8. Key dates 6. Initial bulk lots: Bulk scale up Lot number Toxicology start date Crystallization solvent(s) Clinical supplies preparation IND filing Particle size range Phase I testing Melting point
  • 5. II.Need for a Preformulation Study  Scientific and regulatory justifications for acquiring preformulation data include the following. 1. Establishment of drug specifications intended for toxicologic evaluation and clinical supply preparations 2. Formulation of clinical supplies and establishment of their preliminary Specifications 3. Providing scientific data to support dosage form development and evaluation of product efficacy, quality, stability, and bioavailability 4. Evaluation of the stability of early developed dosage forms 5. Fulfillment of the requirement of the CMC section of the IND and subsequent NDA or ANDA
  • 6. III. Stages of Preformulation Studies  The preformulation is performed in several stages with different development cycles, which are discussed in the following.  Preformulation Report, Part 1: Physicochemical Properties and Analytical Testing for Drugs  Preformulation Report, Part 2: Data Supporting the Development of Dosage Forms  Preformulation Report, Part 3: Support for Quality Control and Finished Product Manufacturing
  • 7. IV.Analytical techniques and instruments for preformulation studies:  A preformulation study is performed to gain insight from physicochemical and biological data into the design and development of dosage forms.  Samples are taken in each study and analyzed qualitatively and/or quantitatively, according to the need.  Analytical techniques are generally divided into two prevalent areas in the specific detection and separation sciences.
  • 8. Analytical Preformulation Attribute Test Identity Nuclear magnetic resonance (NMR) Infra red spectroscopy (IR) Ultraviolet spectroscopy (UV) Thin-layer chromatography (TLC) Differential scanning calorimetry (DSC) Optical rotation, where applicable Purity Moisture (water and solvents) Inorganic elements Heavy metals Organic impurities Differential scanning calorimetry (DSC) Melting point Assay and Separation Titration Ultraviolet spectroscopy (UV) High-performance liquid chromatography (HPLC) Thin-layer chromatography (TLC)
  • 9. A. Specific Detection  Specific detection is based on specific responses related to the chemical characteristics of a molecule excited by a certain type of irradiation.  In this detection method, measurement of the molecule of interest may usually be performed without separation from matrix materials or from other ingredients if appropriate instrumental adjustments are made.  Techniques such as Fourier transform IR (FTIR), attenuated total reflectance (ATR), NIR, Raman spectroscopy are used with increased regularity.  The detection of foreign metal contaminants is essential with inductively coupled plasma spectroscopy (ICP), atomic absorption (AA), and X-ray fluorescence.
  • 10. 1.UV spectroscopy  UV absorptions are mainly electronic in nature and are associated with resonating structures in the molecule.  The UV quantitative determination, generally performed in solution, is based on the Beer–Lambert law.  In a Preformulation study, Certain UV techniques are worthy of discussion:  Solubility,  Dissolution rate,  Molecular weight  pKa  Assay (potency)  Mixtures:  - resolving compound products  Stability studies : hydrolysis, oxidation ,when degradation products have a different absorption maximum from the parent compound
  • 11.  ionization of benzoic acid affect its aqueous solubility, is also manifested in the ultraviolet absorption spectrum.  Figure shows the UV spectra obtained for a 5 mg/mL solution of benzoic acid in methanol (i.e., the protonated form) and for the same concentration of substance dissolved in 0.1N sodium hydroxide solution (i.e., the ionized form).  The spectrum of the protonated form is dominated by the peak at 228nm (molar absorptivity =11,900 L/mole), while the analogous peak of the ionized form is slightly blue-shifted to 225nm and is significantly less intense (molar absorptivity ¼8640 L/mole)
  • 12. 2.IR Spectroscopy  Used for fingerprint identification of a drug molecule and the proof of its structure.  IR absorption bands are characteristic of the functional group of a molecule as well as the structure configuration.  The wavelength of the IR spectrum is 750–2500 μm.  The sampling preparation techniques for IR determination are solution, drug dispersion in a KBr pellet, Nujol mulls, and direct determination by microscopic ATR preparation.  An example of modern IR equipment is FTIR, which gives better quality determination.
  • 14. 3.Raman Spectroscopy  When a particle is irradiated at a certain frequency, radiation scattered by the molecule contains photons of the same frequency as the incident radiation and may contain photons (weak signal) with a changed or shifted frequency.  A nondestructive tool and requires little or no sample preparation.  A sample may be analyzed in solid or powder form or in an aqueous solution and placed in glass containers such as an NMR tube, GC vial, test tube, light-path cell, or glass bottle.  Aside from structure elucidation and functional group analysis, FT-Raman may be used for quantitative determination of polymorphs in a Preformulation study.
  • 15. 4.NIR Spectroscopy  NIR is making significant progress through recent advances in pharmaceutical analysis.  The advantage of this technique is the rapidity of analytical determinations without sample preparation and the use of solvent.  The NIR spectrum is primarily related to the overtone variation. Hence, the absorption bands are generally weaker than those in the IR.  The wavelength of the NIR spectrum is defined as 2500–3000 μm.  The detection method is nondestructive.  Therefore, it is suitable for use in on-line monitoring and meets 100% inspection requirements in quality control practice.
  • 16. 5.X-Ray Diffraction  obtains information on substance structure at the atomic level.  This technique allows measurement of both crystalline and noncrystalline materials.  The analysis is nondestructive in nature and handles samples in the form of powders, solids, and liquids.  The X-ray diffraction of a single crystal is employed for the determination of the absolute chemical structure.  Quantitative ratios of two polymorphs and their percentage of crystallinity may also be determined.
  • 17.  the XRPD pattern of benzoic acid is shown in Figure  One may define this particular crystal form by the angles of the five most intense scattering peaks, namely 8.15, 10.21, 16.24, 17.20, and 21.67 degrees 2q. Through use of the Bragg equation ,nzλ= 2d sin θ, calculated d-spacings for the five most intense scattering peaks, namely 10.840, 8.657, 5.453, 5.151, and 4.098 A ° , actually constitute a better definitionof this particular crystal form.
  • 18. 6. NMR Spectroscopy  NMR involves the absorption of electromagnetic radiation in the radiofrequency of a longer wavelength spectrum.  When a sample is placed with atomic nuclei of hydrogen (1H, protons), fluorine (15F), or phosphorous (31P) in a magnetic field, absorption of energy will occur.  The nuclei shift from the preferred orientation with lowest energy to a less preferred, high-energy orientation at a particular frequency.  Thus a plot of frequency versus intensity of radiation results in the NMR spectrum of a material.  Spectra of NMR can be obtained in liquids or in solids.  NM R spectra gives information about structure and atomic environment of molecule,
  • 19.  It consist of resonance bands associated with the carbon atoms in the aromatic nucleus and the carbon atom of the carboxylic acid group.
  • 20. 7. Mass Spectroscopy  Mass spectra is the result of detection of charged particles or ions separated according to their mass to charge (m/e) ratio after ionization and acceleration through magnetic field.  Mass spectra gives information about molecular weight of substance and what its degraded or metabolic products will be.  MALDI like techniques are employed for high molecular weight substances like certain proteins.
  • 21. 8. Metal analysis a) Atomic absorption spectroscopy b) ICP Spectroscopy c) X-Ray fluorescence  Pharmaceutical compounds such as ferrous sulfate, ferrous gluconate, zinc undecylenate, and magnesium stearate (a commonly used excipient)  Sodium, potassium, zinc detection for certain preparations like protamine zinc insulin etc.  presence of metal in pharmaceuticals, even in trace amounts, is a form of contaminant. For example, metallic ions may act as a catalyst in oxidation that may be detected in drug products.
  • 22. B. Separation Sciences 1. Thin-Layer Chromatography  impurity profiling in drug development  Involves most convenient, least inexpensive and portable equipment  microscopic technique (it uses a very small sample) is simple and has a short development time  general detection technique is to spray a sample with a detecting agent, which reacts chemically with the ingredient to be detected or visual observation under short- or long-wave UV light is also employed.  The disadvantages of TLC include reproducibility, detection inconsistency, person-to-person variations, documentation, and electronic data reduction.
  • 23.  HPTLC:  to overcome some drawbacks of TLC, especially in quantitative determination, A high-performance instrument has been developed with  a fully automated sample applicator,  a solvent-developing and -evaporating chamber,  a precision-made dryer,  a color developing agent  sprayer,  a light control chamber for visual or photographic observation, and a reflective spectrophometric detector  Ingenious methods of quantitative determination are available that use a flame ionization detector (FID)
  • 24. 2. High-Pressure Liquid Chromatography  HPLC is used extensively in the laboratory for quantization of drugs and related components. Identification of a drug component can simultaneously be determined by retention times in the chromatogram.  reliable analytical tool for Preformulation study because of the high-resolution capacity, accuracy, and reproducibility of the equipment  Its primary function includes  search for and detection of impurities in drug substances,  stability evaluation of dosage forms in terms of detection and quantization of degradation products.  UV detector coupling with Micro-bore HPLC equipment is the most important analytical instrument for Preformulation
  • 25. 3. Capillary Electrophoresis:  A separate technique employing narrow-bore tubes (10–200 μm i.d.) for high-efficiency resolution of both large and small molecules  In free solution capillary electrophoresis (CE), the separation and migration of the molecules through the capillary are based on electrophoretic migration (based on net charge) and electrosomotic flow (the bulk flow of electrolyte buffer)  Other mechanisms for separation depend on molecular size, isoelectric focusing, and hydrophobicity  Modification of CE is micellar electrokinetic chromatography (MEKC), widely used for the separation of nonpolar compounds
  • 26. 4. Gas Chromatography:  GC is used for speedy separation or for high-resolution separation of volatile or thermal labile substances. GC has good sensitivity, with detection limits of 1 ppb to 100 ppm.  With the advances in HPLC, GC is utilized less often. It is still used for the analysis of retained solvents, such as the USP test for volatile organic solvents. 5. Ion Chromatography:  Ion chromatography is a modified version of HPLC with a capacity for precise and highly sensitive detection of inorganic ions in a complex matrix.  IC has instrumental configurations similar to those of HPLC, but the stationary phase is an ion-exchange column, and the detector can be either an electrochemical detector or a colorimeter with a mixer to carry out color formation by chemical reaction with the detected ion
  • 27. 6. Supercritical Fluid Chromatography:  SFC uses highly compressed gas above its critical temperature and pressure instead of an organic solvent as the solvent phase  Gases such as carbon dioxide, nitrous oxide, and ammonia are commonly used  The SFC detecting systems are those commonly used in GC, that is, FID.  Major advantage is allowance in the analysis for thermal unstable compounds
  • 28. C .Thermal Analytical methods 1) Differential Scanning Calorimetry 2) Hot Stage Microscopy 3) Thermal Gravimetric Analysis 4) Solution Calorimetry  DSC is a precise method of measuring the endothermic and exothermic behaviors of sample materials.  TGA measures the weight change (gains and losses) as a function of temperature or time is recorded which provides information about the material’s thermal stability and compositional analysis (e.g., moisture content of the materials).
  • 29.  The gas evolved during the heating process may be detected with FTIR or MS to provide additional information.  TGA may be used to determine moisture content related to weight loss in isothermal or nonisothermal stability studies.  Preformulation study, differentiation of polymorph from hydrate or identification of monohydrate from among other hydrates by DSC alone may not be possible.
  • 30.  The DSC thermogram of benzoic acid is shown and is seen to consist  entirely of an endothermic transition associated with the melting phase transition of the compound.  No thermal events were observed at the lower temperatures indicative of the existence of a solvatomorphic crystal form.  Under the conditions of measurement, the melting endothermic transition is characterized by an onset temperature of 121.9C, a peak maximum of 123.7C, and an enthalpy of fusion equal to 138.9 J/g
  • 31. V. Regulatory requirements for Preformulation A. Regulatory Compliance:  FDA initiatives and other government regulations influence pharmaceutical manufacturing operations, including Preformulation studies and quality control systems. 1) Current Good Manufacturing Practices:  The cGMP is an FDA mandatory quality program designed to ensure that pharmaceutical products are consistently produced and controlled according to the quality standards appropriate to their intended use. 2) Good Laboratory Practice:  GLP covers research activities like raw data, documentation, standard operating procedures (SOP), protocols, final reports, and specimens (with some exceptions) must be retained.
  • 32. 3) International Conference on Harmonization:  The ICH is intended to avoid duplication efforts for product registration and manufacturing in world trade from the United States, the European Union, and Japan to harmonize regulatory criteria and procedures.  Ultimately, there will be one set of global requirements. Area of interest are  Stability testing  Quality specification (including impurities)  Validation of manufacturing procedures and analytical methods  CMC sections for product registration  Toxicity testing  Clinical testing of biotechnology-derived products
  • 33. B. Quality Control for a Preformulation Study  Personnel Qualification and Training  Analytical Method Validation  Written analytical procedure  Instrument calibration  Validation parameters: accuracy, precision, linearity, sensitivity  System suitability criteria: the minimum acceptable performance criteria before each analysis  Documentation and Standard Operating Procedures
  • 34. APPENDIX 1: PHYSICOCHEMICAL PROPERTIES AND ANALYTICAL TESTING FOR DRUG SUBSTANCE Chemical Structure Empirical Formula Molecular Weight  Lot # of Drug Used: Reported By:  Assay: Position:  Reference: Notebook # Date of Report Issued: 1. Chemical Properties 2. Identification of Drug Substance Chemical structure UV Molecular weight IR Empirical formula NMR Elemental analysis (C, H, N, O, Cl, etc.) Mass spectroscopy TLC Rf and HPLC retention time Melting point
  • 35. 3. Titration Methods 6. Synthetic Impurities Nonaqueous titration with curve  Starting materials a: name and Other titration methods structure 4. Chromatographic Techniques  Pivotal impurities b: name and and Method Description structure TLC  Degradant from synthesis c: name and HPLC structure GPC  Other minor impurities d: name and Others structure 5. Proposed Assay Methods for  Description of Method of Detection Drug Substance 7. HPLC Data Titration Impurities Retention Time  UV 1.  HPLC 2.  GC 3.  Others Typical chromatogram attached Description 8. Optical Rotation Typical spectrograph attached (Figure ) Comments
  • 36. 9. Solubility 11. Partition Coefficient  Solubility in water and organic solvents: Value: mg/ml System:  Aqueous Solubility as a Function of 12. Loss on Drying Temperature Drying temperature: Temperature ( C) Solubility :mg/ml Time period: Aqueous Solubility at Various Buffered pH Condition: _ in oven, _ in vacuo Values LOD in percent: pH Solubility (mg/ml) Buffer system Solubility with Surfactants Surfactant/Concentration Solubility (mg/ml) 10. Dissociation Constant, pKa pKa value: Method of determination:
  • 37. VII . References 1. Satinder Ahuja, Stephen Scypinski, Handbook of Modern Pharmaceutical Analysis, pp173-233. 2. Leon Lachman, Herbet A.Lieberman, A theory and practice of Industrial Pharmacy, special Indian edition -2009,pp 171-196 3. M.E.Aulton, Pharmaceutics The science of Dosage Form Design, Second edition, pp113-138 4. Gilbert S. Banker, Christopher T. Rhodes, Modern Pharmaceutics, Fourth edition, Marcel dekker,Inc. 5. Moji Christianah Adeyeye , Harry G. Brittain, Preformulation in solid dosage form development, Informa healhcare Inc.-2008,pp1-15,115-145.